[RadioTransNet, the French network for preclinical research in oncological radiotherapy]

Area of Science:

• Oncology
• Radiotherapy Research
• Translational Medicine

Background:

• The French National Cancer Institute (INCa) launched RADIOTRANSNET in late 2018.
• The network aims to bridge preclinical radiotherapy research and clinical application.
• It focuses on fostering interactions between radiation oncology, medical physics, and biology.

Purpose of the Study:

• To establish a French research consortium for preclinical radiotherapy.
• To identify research priorities and foster innovation in radiotherapy.
• To create a strategic research agenda and roadmap for national efforts.

Main Methods:

• Organizing activities around four key axes: target definition, normal tissue, combined treatments, and dose modeling.
• Supervision by a Scientific Council with designated coordinators.
• Utilizing a consensus conference methodology led by radiation oncologists, medical physicists, and biologists to identify priority issues.

Main Results:

• The network structure facilitates coordination among diverse stakeholders in preclinical radiotherapy.
• Identification of key research themes to guide future innovation.
• Development of a strategic agenda to direct national research efforts.

Conclusions:

• The RADIOTRANSNET network is crucial for coordinating preclinical radiotherapy research in France.
• It promotes scientific and clinical interactions to drive innovation in radiation oncology.
• The established roadmap will guide funding and resource allocation for future research.